By HFT Editorial Staff

The Centers for Disease Control and Prevention (CDC) recently awarded $22 million to nearly 30 organizations to combat antimicrobial resistance (AR) and other healthcare threats through the establishment of two new networks — the Global Action in Healthcare Network and the Global AR Laboratory and Response Network.

These two new networks, paired with additional short-term research projects, will span more than 50 countries worldwide and build programs that: focus on preventing infections in healthcare through proven infection control; build laboratory capacity to detect antimicrobial-resistant organisms in healthcare, the community, and environment; and develop new and innovative ways to more rapidly detect and respond to threats such as AR and COVID-19.

This work builds on successful U.S. efforts launched through CDC’s AR Solutions Initiative since 2016 and will complement ongoing, effective global work underway by CDC and public health partners worldwide. These networks and research projects will tackle threats covered in CDC’s Antibiotic Resistance Threats in the United States, 2019 and other healthcare-associated infections.